您当前的位置：
首页 >
文章列表页 >
Cost-effectiveness analysis of tafolecimab in patients with hypercholesterolemia
更新时间：2025-11-25

    • Cost-effectiveness analysis of tafolecimab in patients with hypercholesterolemia

    • “The latest research shows that under the Chinese healthcare system, the regimen of injecting Trastuzumab 150 mg once every two weeks improves the health outcomes of patients with hypercholesterolemia and is economically viable.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 22, Pages: 2815-2821(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.22.11    

      CLC： R972+.6;R956

    • Received：08 July 2025，

      Revised：2025-10-31，

      Accepted：31 October 2025，

      Published：30 November 2025

    移动端阅览

  • LI Tong,ZHANG Xinyue,FENG Mengwen,et al.Cost-effectiveness analysis of tafolecimab in patients with hypercholesterolemia[J].ZHONGGUO YAOFANG,2025,36(22):2815-2821. DOI： 10.6039/j.issn.1001-0408.2025.22.11.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Pharmacoeconomic evaluation of finerenone combined with standard treatment regimen in the treatment of diabetic nephropathy
Pharmacoeconomic evaluation of trastuzumab deruxtecan versus chemotherapy in the second-line treatment of advanced breast cancer with HER-2 low expression
Pharmacoeconomics of ivabradine in the treatment of CHF in the context of “Quadruple Therapy”
Study on pharmacoeconomic evaluation of vericiguat in the treatment of heart failure with reduced ejection fraction
Cost-effectiveness of regorafenib for hepatocellular carcinoma after failure of sorafenib

Related Author

XIA Runan
DI Panpan
ZHAO Mengmeng
ZHANG Pengcheng
HOU Yashen
ZHANG Hong
WU Wei
LIANG Hai

Related Institution

Dept. of Pharmacy， the People’s Hospital of Bozhou
Breast Center， the Fourth Hospital of Hebei Medical University
Dept. of Clinical Pharmacology， the Fourth Hospital of Hebei Medical University
Dept. of Pharmacy， the Fourth Hospital of Hebei Medical University
Dept. of Cardiology， Nanjing Drum Tower Hospital
0